Genvec

GenVec was a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Gaithersburg, Maryland, that pioneered adenovector (AdenoVerse) gene-delivery technology to develop gene-based therapeutics and vaccines, including programs for hearing loss and balance disorders. Backed by Canaan Partners, ARCH Venture Partners, EDF Ventures and HealthCare Ventures, GenVec was acquired by Precigen (formerly Intrexon) on June 16, 2017 and no longer operates as an independent company. It has no public developer platform, API, or documentation surface; the genvec.com domain no longer resolves.

Genvec is profiled on the APIs.io network. Tagged areas include Company, Biopharmaceutical, Gene Therapy, Vaccines, and Biotechnology.

🌐 Visit website 📡 Source on GitHub
6.8/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyBiopharmaceuticalGene TherapyVaccinesBiotechnologyGene Delivery

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 6.8/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.0 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/genvec: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Source (apis.yml)

apis.yml Raw ↑ 
aid: genvec
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/genvec.png
name: Genvec
description: GenVec was a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Gaithersburg, Maryland,
  that pioneered adenovector (AdenoVerse) gene-delivery technology to develop gene-based therapeutics and vaccines, including
  programs for hearing loss and balance disorders. Backed by Canaan Partners, ARCH Venture Partners, EDF Ventures and HealthCare
  Ventures, GenVec was acquired by Precigen (formerly Intrexon) on June 16, 2017 and no longer operates as an independent
  company. It has no public developer platform, API, or documentation surface; the genvec.com domain no longer resolves.
url: https://raw.githubusercontent.com/api-evangelist/genvec/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- canaan-partners
x-tier: stub
x-tier-reason: portfolio-lead
x-status: acquired
x-acquired-by: precigen
x-acquired-date: '2017-06-16'
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Biopharmaceutical
- Gene Therapy
- Vaccines
- Biotechnology
- Gene Delivery
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-20'
  status: nochange
  artifacts_added: 0
  pass: local-v1